Literature DB >> 32489944

Recent prospective data regarding good survival outcome after radiofrequency ablation of lung metastases from colorectal cancer: the radiation oncologist point of view.

Linda Agolli1,2, Luca Nicosia3.   

Abstract

Entities:  

Year:  2020        PMID： 32489944      PMCID： PMC7242308          DOI： 10.21037/qims-2020-13

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN： 2223-4306


× No keyword cloud information.
  17 in total

Review 1.  What to choose as radical local treatment for lung metastases from colo-rectal cancer: surgery or radiofrequency ablation?

Authors:  Roel C J Schlijper; Janneke P C Grutters; Ruud Houben; Anne-Marie C Dingemans; Joachim E Wildberger; Dirk Van Raemdonck; Eric Van Cutsem; Karin Haustermans; Guido Lammering; Philippe Lambin; Dirk De Ruysscher
Journal:  Cancer Treat Rev       Date:  2013-06-13       Impact factor: 12.111

2.  Three-year Survival Rate after Radiofrequency Ablation for Surgically Resectable Colorectal Lung Metastases: A Prospective Multicenter Study.

Authors:  Takaaki Hasegawa; Haruyuki Takaki; Hiroshi Kodama; Takashi Yamanaka; Atsuhiro Nakatsuka; Yozo Sato; Motoshi Takao; Yoshihiko Katayama; Ichiro Fukai; Toshio Kato; Toshiya Tokui; Hironori Tempaku; Katsutoshi Adachi; Yasushi Matsushima; Yoshitaka Inaba; Koichiro Yamakado
Journal:  Radiology       Date:  2020-01-14       Impact factor: 11.105

3.  Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".

Authors:  Juliane Rieber; Jan Streblow; Lorenz Uhlmann; Michael Flentje; Marciana Duma; Iris Ernst; Oliver Blanck; Andrea Wittig; Judit Boda-Heggemann; Robert Krempien; Fabian Lohaus; Nathalie Desirée Klass; Michael J Eble; Detlef Imhoff; Henning Kahl; Cordula Petersen; Sabine Gerum; Christoph Henkenberens; Sonja Adebahr; Peter Hass; Elsge Schrade; Thomas G Wendt; Guido Hildebrandt; Nicolaus Andratschke; Florian Sterzing; Matthias Guckenberger
Journal:  Lung Cancer       Date:  2016-04-26       Impact factor: 5.705

4.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

Authors:  David A Palma; Robert Olson; Stephen Harrow; Stewart Gaede; Alexander V Louie; Cornelis Haasbeek; Liam Mulroy; Michael Lock; George B Rodrigues; Brian P Yaremko; Devin Schellenberg; Belal Ahmad; Gwendolyn Griffioen; Sashendra Senthi; Anand Swaminath; Neil Kopek; Mitchell Liu; Karen Moore; Suzanne Currie; Glenn S Bauman; Andrew Warner; Suresh Senan
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

5.  30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease.

Authors:  M F Osti; L Agolli; M Valeriani; C Reverberi; S Bracci; L Marinelli; V De Sanctis; E Cortesi; M Martelli; C De Dominicis; G Minniti; L Nicosia
Journal:  Lung Cancer       Date:  2018-06-13       Impact factor: 5.705

6.  Radiofrequency-assisted versus clamp-crushing parenchyma transection in cirrhotic patients with hepatocellular carcinoma: a randomized clinical trial.

Authors:  Min Li; Wei Zhang; Yi Li; Peizhi Li; Jinzheng Li; Jianping Gong; Yongjun Chen
Journal:  Dig Dis Sci       Date:  2012-09-25       Impact factor: 3.199

7.  A systematic review and meta-analysis of stereotactic body radiation therapy for colorectal pulmonary metastases.

Authors:  Christopher Cao; Daniel Wang; David H Tian; Ashley Wilson-Smith; James Huang; Andreas Rimner
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

8.  Intermittent Pringle maneuver may be beneficial for radiofrequency ablations in situations with tumor-vessel proximity.

Authors:  Franz G M Poch; Christina A Neizert; Ole Gemeinhardt; Beatrice Geyer; Katharina Eminger; Christian Rieder; Stefan M Niehues; Janis Vahldiek; Stefan F Thieme; Kai S Lehmann
Journal:  Innov Surg Sci       Date:  2018-05-11

9.  Comparison of internally cooled wet electrode and hepatic vascular inflow occlusion method for hepatic radiofrequency ablation.

Authors:  Mi-Hyun Park; June-Sik Cho; Byung Seok Shin; Gyeong Sik Jeon; Byungmo Lee; Kichang Lee
Journal:  Gut Liver       Date:  2012-08-07       Impact factor: 4.519

10.  A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.

Authors:  Xin Wang; Leonid Zamdborg; Hong Ye; Inga S Grills; Di Yan
Journal:  BMC Cancer       Date:  2018-10-10       Impact factor: 4.430
View more
  1 in total

Review 1.  Combined with interventional therapy, immunotherapy can create a new outlook for tumor treatment.

Authors:  Tonglei Fang; Junyuan Xiao; Yiran Zhang; Haiyan Hu; Yueqi Zhu; Yingsheng Cheng
Journal:  Quant Imaging Med Surg       Date:  2021-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.